NRC Health Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31)
NRC Health (NRC) reported Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) of $337.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-03.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions · last filed 2017-03-03
- NRC Health employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2016 was $337.00K, a 114.65% increase from fiscal 2015.
- NRC Health employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2015 was $157.00K, a 74.76% decline from fiscal 2014.
- NRC Health employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2014 was $622.00K, a 17.40% decline from fiscal 2013.
- NRC Health employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2013 was $753.00K, a 62.35% decline from fiscal 2012.
| Period end | Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) 12 month | Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) 12 month as first filed |
|---|---|---|
| 2016-12-31 | $337.00K 10-K · filed 2017-03-03 | |
| 2015-12-31 | $157.00K 10-K · filed 2017-03-03 | $217.00K 10-K · filed 2016-03-04 |
| 2014-12-31 | $622.00K 10-K · filed 2017-03-03 | |
| 2013-12-31 | $753.00K 10-K · filed 2016-03-04 | |
| 2012-12-31 | $2.00M 10-K · filed 2015-03-04 | |
| 2011-12-31 | $350.00K 10-K · filed 2014-03-04 | |
| 2010-12-31 | $43.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |